Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study

Pablo Tolosa, Tomás Pascual, Olga Martínez‐Sáez, Cristina Hernándo, Sònia Servitja, María Fernández, Fara Brasó‐Maristany, Esther Sanfeliu, Javier David Benítez Fuentes, Laura Lema, Yolanda Ruano, Isabel García-Fructuoso, Lucía Parrilla, A. Rodríguez, Ana Maria Roncero Sanchez, María Cobos-Fernández, Rodrigo Sánchez-Bayona, Manuel Alva, Ainhoa Madariaga, Guillermo Villacampa, Jordi Canes, Fernando Salvador, Agustín Sánchez-Belmonte, Marcos Malumbres, Aleix Prat, Eva Ciruelos